← Back to patent-cliff list
I-025-A
Tier C — Watch / tradeI-025-A
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：HER2
Indications (approved)：Colorectal cancer, Breast cancer
Regional status
US
-
EU
-
China
Phase II
2024-12-31
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of I-025-A?
Approved indications include: Colorectal cancer, Breast cancer.
When does the I-025-A patent expire?
No public expiry year is available for I-025-A yet; this page updates once verified.
How do I get a quote for I-025-A intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01